Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V T Farewell

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Biometrics|December 1, 1994
Guidelines for monitoring efficacy and toxicity responses in clinical trialsR J Cook, V T Farewell
Biometrics|June 1, 1982
On testing for a constant hazard against a change-point alternativeD E Matthews, V T Farewell
Statistics in Medicine|July 12, 2002
A Pearson-type goodness-of-fit test for stationary and time-continuous Markov regression modelsR Aguirre-Hernández, V T Farewell
Arthritis and Rheumatism|June 1, 1995
The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Multivariate relative risk modelD D Gladman, V T Farewell
BMJ (Clinical Research Ed.)|January 4, 1997
Statistical basis of public policy. Qualitative and quantitative aspects should not be confusedD R Cox, V T Farewell
Tissue Antigens|January 1, 1986
An extension of Green and Woodrow's sibling method for detecting MHC-disease associationsV T Farewell, W C Ladiges
The Journal of Rheumatology|November 11, 1999
Progression in psoriatic arthritis: role of time varying clinical indicatorsD D Gladman, V T Farewell
Biometrics|April 25, 2001
The utility of mixed-form likelihoodsR J Cook, V T Farewell
Biometrics|December 1, 1988
The use of a mixture model in the analysis of count dataV T Farewell, D A Sprott
Annual Review of Public Health|January 1, 1986
Relative risk and odds ratio regressionR L Prentice, V T Farewell
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Biometrics|December 1, 1994
Guidelines for monitoring efficacy and toxicity responses in clinical trialsR J Cook, V T Farewell
Biometrics|June 1, 1982
On testing for a constant hazard against a change-point alternativeD E Matthews, V T Farewell
Statistics in Medicine|July 12, 2002
A Pearson-type goodness-of-fit test for stationary and time-continuous Markov regression modelsR Aguirre-Hernández, V T Farewell
Arthritis and Rheumatism|June 1, 1995
The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Multivariate relative risk modelD D Gladman, V T Farewell
BMJ (Clinical Research Ed.)|January 4, 1997
Statistical basis of public policy. Qualitative and quantitative aspects should not be confusedD R Cox, V T Farewell
Tissue Antigens|January 1, 1986
An extension of Green and Woodrow's sibling method for detecting MHC-disease associationsV T Farewell, W C Ladiges
The Journal of Rheumatology|November 11, 1999
Progression in psoriatic arthritis: role of time varying clinical indicatorsD D Gladman, V T Farewell
Biometrics|April 25, 2001
The utility of mixed-form likelihoodsR J Cook, V T Farewell
Biometrics|December 1, 1988
The use of a mixture model in the analysis of count dataV T Farewell, D A Sprott
Annual Review of Public Health|January 1, 1986
Relative risk and odds ratio regressionR L Prentice, V T Farewell
Pageof 10